Kyverna Therapeutics, Inc.
$8.35
-0.12 (-1.47%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +11.2%
- 3 Months
- +5.7%
- YTD
- -11.2%
- 1 Year
- +125.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 100.7%
- Largest decline max drawdown, since Aug 2025
- -37.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.31
Own KYTX?
See how KYTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.